« PERSONAL PERSPECTIVE / It's a family decision | Main | The Infinite Mind: Multiple Sclerosis »

Elan Faces SEC Inquiry Into Trading

Elan Corp. (ELN.I: Quote, Profile, Research) (ELN.N: Quote, Profile, Research) on Monday said the U.S. Securities and Exchange Commission is probing securities trading around the Feb. 28 announcement of the suspension of sales of the multiple sclerosis drug Tysabri.

Probe here.

April 11, 2005 in follow the money... | Permalink

Comments